SIGN Publish New Chronic Heart Failure Guidelines Version for Patients A new patient version of the SIGN Chronic Heart Failure guidelines was published this week for people with Chronic ‪‎Heart Failure‬ in Scotland and their family, friends and carers. This new booklet explains the recommendations set out in a clinical guideline (published in March) produced […]

We put some common questions to Dr Rick Steeds, Consultant Cardiologist, Queen Elizabeth Hospital Birmingham and Chair of the British Society of Echocardiology (BSE) about Echocardiography and heart failure Alongside his practice in general Cardiology, Rick sub-specialises in cardiac imaging and the management of valvular heart disease. He very kindly, and purposefully answers our questions to […]

Happy 25th Heart Day from Pumping Marvelllous Today, Pumping Marvellous the UK’s heart failure charity are wishing Arthur Whitfield a very special birthday indeed. 25 years ago today Arthur was very fortunate to receive a heart transplant at Harefield Hospital, following a tip off from Buckingham Palace! (Read more.) On hearing Arthur’s story, Pumping Marvellous […]

92-year-old Arthur Whitfield Celebrates his 25th Heart Transplant Birthday At the time of his heart transplant in 1991, Arthur Whitfield then aged 67, was the oldest person to receive a donor heart. 25 years later, determined Arthur today is celebrating being one of oldest, if the not the eldest heart transplant patients in the world! […]

COMPETITION: WIN (One of Twelve) AliveCor ECG mobile devices RRP £79!

NICE says ‘Yes’ to new heart failure medicine, Entresto™ (sacubitril/valsartan), in final recommendation * NICE recognises Entresto sacubitril valsartan as an innovative and cost-effective treatment in the management of symptomatic chronic heart failure with reduced ejection fraction * Heart failure affects around 550,000 people in the UK and has a poor prognosis for many patients, […]

NICE Publish Final Appraisal Determination for Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction National Institute for Health and Care Excellence (NICE) Recommendations in Final Appraisal Determination for Sacubitril valsartan Recommendations 1.1 Sacubitril valsartan is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction, only in people:  […]

Novartis’ new heart failure medicine, Entresto™, sacubitril valsartan accepted for use in Scotland by the Scottish Medicines Consortium  SMC recognised sacubitril valsartan represents a new therapeutic option for adult patients with symptomatic chronic heart failure with reduced ejection fraction1and may be used instead of the current gold standard treatment for the condition  Heart […]

Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure  For the first time in the U.S., a clinical trial is underway that’s evaluating a transcatheter implant device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center. Diastolic […]

A VALENTINE WISH FOR THE NHS – Love is being smart together The NHS will last as long as there are folk left with the faith to fight for it’ – Nye Bevan A Valentine Wish For The NHS “Love is being stupid together,” so wrote the French poet Paul Valery. While I feel there’s […]

Boston Scientific and Accenture Develop Data-Driven Digital Heart Failure Management Service in Parts of Europe to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions Care Pathway Transformation solution is designed to enable providers to make better-informed decisions based on patient population insights with a new Heart Failure Management Service Boston Scientific Corporation […]

Novartis’ new heart failure medicine Sacubitril valsartan is now available in the UK Sacubitril valsartan (Entresto™) is now available for UK adults with symptomatic chronic heart failure with reduced ejection fraction Largest heart failure study showed Entresto (sacubitril valsartan) saves lives and reduces hospitalisation for people with heart failure when compared to enalapril, an ACE-inhibitor, and […]

£3-a-day heart failure drug Sacubitril valsartan, described as biggest breakthrough in 15 years after reducing death rates by 20%, available tomorrow and on NHS from May Breakthrough heart failure drug Sacubitril valsartan to be made available to private patients from tomorrow The breakthrough drug is expected to be available from the NHS by May 2016 Clnical […]

Public Health England issues guidance as Met Office updates Level 2 cold weather alert As colder weather sweeps across the country, the Met Office has today (13 January 2015) updated the Level 2 cold weather alert. This now affects all parts of England. [Cold Weather Alert: See Pumping Marvellous Winter Survival Kit for Heart Patients – […]

Penn Researchers Identify Cause of Heart Failure in Pregnant Women Data shows genetic mutation in the TITIN protein causes Peripartum Cardiomyopathy Each year approximately 1 in 1,000 pregnant women will experience peripartum cardiomyopathy, PPCM, an uncommon form of often severe heart failure that occurs in the final month of pregnancy or up to five months […]